Cargando…

Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens

In 2016, surgery is the standard of care for peripheral stage I non-small cell lung cancer. However, recent thought-provoking randomized evidence suggests stereotactic ablative body radiotherapy (SABR) has survival outcomes similar to those of surgery. Albeit limited, patient-reported outcomes and q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siva, Shankar, Ball, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AlphaMed Press 2016
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828125/ https://www.ncbi.nlm.nih.gov/pubmed/26984447 http://dx.doi.org/10.1634/theoncologist.2015-0477

Ejemplares similares

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
por: Malone, Julia, et al.
Publicado: (2020)

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer
por: Okoye, Christian C., et al.
Publicado: (2020)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer
por: Barry, Aisling, et al.
Publicado: (2018)

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
por: David, Steven, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019)

Stereotactic Radiotherapy for Stage I Small Cell Lung Cancer
por: Verma, Vivek, et al.
Publicado: (2016)

A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer
por: Akanda, Zarique Z., et al.
Publicado: (2021)

Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer
por: KIM, MIN-JEONG, et al.
Publicado: (2013)

Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer
por: Dubaere, Emilie, et al.
Publicado: (2019)

Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018)

Radiofrequency ablation vs. stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients
por: Li, Ming, et al.
Publicado: (2021)

Complications from Stereotactic Body Radiotherapy for Lung Cancer
por: Kang, Kylie H., et al.
Publicado: (2015)

Stereotactic ablative radiotherapy versus lobectomy for stage I non‐small cell lung cancer: A systematic review
por: Wang, Siwei, et al.
Publicado: (2018)

SUVmax Predicts Disease Progression after Stereotactic Ablative Radiotherapy in Stage I Non-small Cell Lung Cancer
por: Kwak, Yoo-Kang, et al.
Publicado: (2020)

Changes in volume of stage I non-small-cell lung cancer during stereotactic body radiotherapy
por: Tatekawa, Kotoha, et al.
Publicado: (2014)

Choice of Treatment for Stage IA Non-small Cell Lung Cancer Patients Ineligible for Surgery: Ablation or Stereotactic Body Radiotherapy?
por: Liang, Long, et al.
Publicado: (2020)

Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer
por: Grant, Jonathan D., et al.
Publicado: (2014)

Stereotactic ablative body radiotherapy versus conventionally fractionated radiotherapy for early stage large cell neuroendocrine carcinoma of the lung
por: Wegner, Rodney E, et al.
Publicado: (2020)

Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
por: Chang, Joe Y, et al.
Publicado: (2012)

Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer
por: Kocak Uzel, Esengul, et al.
Publicado: (2023)

Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma
por: Reynolds, Hayley M., et al.
Publicado: (2018)

Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer
por: Guckenberger, M., et al.
Publicado: (2013)

An awakening in the force—The birth of ERCSP
por: Desselle, Shane P., et al.
Publicado: (2021)

Real-World Results of Stereotactic Body Radiotherapy for 399 Medically Operable Patients with Stage I Histology-Proven Non-Small Cell Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2023)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
por: Ma, Ting Martin, et al.
Publicado: (2020)

Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer
por: Inoue, Tetsuya, et al.
Publicado: (2013)

Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
por: Goldsmith, Christy, et al.
Publicado: (2012)

Survey of current practices from an international task force for gynecological stereotactic ablative radiotherapy
por: Leung, E., et al.
Publicado: (2020)

Stereotactic Body Radiotherapy for Early Stage Lung Cancer
por: Nagata, Yasushi
Publicado: (2013)

Immune Responses following Stereotactic Body Radiotherapy for Stage I Primary Lung Cancer
por: Maehata, Yoshiyasu, et al.
Publicado: (2013)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer
por: Shen, Ze-Tian, et al.
Publicado: (2015)

Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience
por: Shioyama, Yoshiyuki, et al.
Publicado: (2013)

NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy
por: Hardcastle, Nicholas, et al.
Publicado: (2019)

A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer
por: Li, Can, et al.
Publicado: (2020)

Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer
por: Hardcastle, Nicholas, et al.
Publicado: (2021)

Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting
por: Heal, Cory, et al.
Publicado: (2015)

Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis
por: Zhang, Ran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9hcncue9hlik2gme0stcjij0ff